169 related articles for article (PubMed ID: 9600782)
1. Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation.
Gao Y; Morita I; Maruo N; Kubota T; Murota S; Aso T
Bone; 1998 May; 22(5):487-93. PubMed ID: 9600782
[TBL] [Abstract][Full Text] [Related]
2. Interaction of triiodothyronine with 1alpha,25-dihydroxyvitamin D3 on interleukin-6-dependent osteoclast-like cell formation in mouse bone marrow cell cultures.
Schiller C; Gruber R; Ho GM; Redlich K; Gober HJ; Katzgraber F; Willheim M; Hoffmann O; Pietschmann P; Peterlik M
Bone; 1998 Apr; 22(4):341-6. PubMed ID: 9556133
[TBL] [Abstract][Full Text] [Related]
3. 17Beta-estradiol antagonizes effects of 1alpha,25-dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures.
Schiller C; Gruber R; Redlich K; Ho GM; Katzgraber F; Willheim M; Pietschmann P; Peterlik M
Endocrinology; 1997 Nov; 138(11):4567-71. PubMed ID: 9348179
[TBL] [Abstract][Full Text] [Related]
4. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
Romas E; Udagawa N; Zhou H; Tamura T; Saito M; Taga T; Hilton DJ; Suda T; Ng KW; Martin TJ
J Exp Med; 1996 Jun; 183(6):2581-91. PubMed ID: 8676079
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines.
O'Brien CA; Lin SC; Bellido T; Manolagas SC
J Cell Biochem; 2000 Sep; 79(4):532-41. PubMed ID: 10996844
[TBL] [Abstract][Full Text] [Related]
6. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P; Persson E; Conaway HH; Lerner UH
J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura T; Udagawa N; Takahashi N; Miyaura C; Tanaka S; Yamada Y; Koishihara Y; Ohsugi Y; Kumaki K; Taga T
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11924-8. PubMed ID: 8265649
[TBL] [Abstract][Full Text] [Related]
8. Chinese hamster ovary cells expressing alpha4beta1 integrin stimulate osteoclast formation in vitro.
Akatsu T; Ono K; Murakami T; Katayama Y; Nishikawa M; Wada S; Yamamoto M; Kugai N; Matsuura N; Takada Y; Nagata N
J Bone Miner Res; 1998 Aug; 13(8):1251-9. PubMed ID: 9718193
[TBL] [Abstract][Full Text] [Related]
9. The biological roles of the third component of complement in osteoclast formation.
Sato T; Abe E; Jin CH; Hong MH; Katagiri T; Kinoshita T; Amizuka N; Ozawa H; Suda T
Endocrinology; 1993 Jul; 133(1):397-404. PubMed ID: 8319587
[TBL] [Abstract][Full Text] [Related]
10. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
11. Soluble IL-6R alpha upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells.
Barillé S; Collette M; Thabard W; Bleunven C; Bataille R; Amiot M
Cytokine; 2000 Sep; 12(9):1426-9. PubMed ID: 10976008
[TBL] [Abstract][Full Text] [Related]
12. Induction of calcitonin receptors by 1 alpha, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells.
Takahashi N; Akatsu T; Sasaki T; Nicholson GC; Moseley JM; Martin TJ; Suda T
Endocrinology; 1988 Sep; 123(3):1504-10. PubMed ID: 2841098
[TBL] [Abstract][Full Text] [Related]
13. Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells.
Kukita A; Kukita T; Hata K; Kurisu K; Kohashi O
Bone Miner; 1993 Nov; 23(2):113-27. PubMed ID: 8305877
[TBL] [Abstract][Full Text] [Related]
14. Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation.
Betz UA; Müller W
Int Immunol; 1998 Aug; 10(8):1175-84. PubMed ID: 9723704
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture.
Kasono K; Sato K; Sato Y; Tsushima T; Shizume K; Demura H
Bone Miner; 1993 Jun; 21(3):179-88. PubMed ID: 8400918
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time.
Tsurukai T; Takahashi N; Jimi E; Nakamura I; Udagawa N; Nogimori K; Tamura M; Suda T
J Cell Physiol; 1998 Oct; 177(1):26-35. PubMed ID: 9731742
[TBL] [Abstract][Full Text] [Related]
18. Estrogen blocks parathyroid hormone-stimulated osteoclast-like cell formation in modulating differentiation of mouse marrow stromal cells in vitro.
Liu BY; Wu PW; Hsu YT; Leu JS; Wang JT
J Formos Med Assoc; 2002 Jan; 101(1):24-33. PubMed ID: 11911034
[TBL] [Abstract][Full Text] [Related]
19. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.
Erices A; Conget P; Rojas C; Minguell JJ
Exp Cell Res; 2002 Oct; 280(1):24-32. PubMed ID: 12372336
[TBL] [Abstract][Full Text] [Related]
20. Role of ascorbic acid in the osteoclast formation: induction of osteoclast differentiation factor with formation of the extracellular collagen matrix.
Otsuka E; Kato Y; Hirose S; Hagiwara H
Endocrinology; 2000 Aug; 141(8):3006-11. PubMed ID: 10919289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
